Best Education For Design
Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard
START A COURSE
READ MORE
Best Education For Design
Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard
START A COURSE
READ MORE
Best Education For Design
Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard
START A COURSE
Best Education For Design
Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard
START A COURSE
MORE INFORMATION
Best Education For Design
Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard
START A COURSE
LINKEDIN PAGE
Best Education For Design
Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard
START A COURSE
READ NOW
Best Education For Design
Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard
START A COURSE
WATCH THE VIDEO
Welcome To IRDiRC
Our vision: Enable all people living with a rare disease to receive an accurate diagnosis, care, and available therapy within one year of coming to medical attention
Goal 1
All patients coming to medical attention with a suspected rare disease will be diagnosed within one year if their disorder is known in the medical literature; all currently undiagnosable individuals will enter a globally coordinated diagnostic and research pipeline
Goal 2
1000 new therapies for rare diseases will be approved, the majority of which will focus on diseases without approved options
Goal 3
Methodologies will be developed to assess the impact of diagnoses and therapies on rare disease patients
Latest News
Mark your calendars for WODC USA!
Only 8 days to go until the World Orphan Drug Congress USA 2024…
Alexion – NMOSD Mental Health Study
“My care team consists of over 30 healthcare professionals and I can’t recall…
CDMRP: FY24 Research Funding Opportunities
The Congressionally Directed Medical Research Programs (CDMRP) announces new FY24 Research Funding Opportunities…